376 related articles for article (PubMed ID: 34468293)
1. Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States.
Davis AK; Agin-Liebes G; España M; Pilecki B; Luoma J
J Psychoactive Drugs; 2022; 54(4):309-318. PubMed ID: 34468293
[TBL] [Abstract][Full Text] [Related]
2. Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.
Corrigan K; Haran M; McCandliss C; McManus R; Cleary S; Trant R; Kelly Y; Ledden K; Rush G; O'Keane V; Kelly JR
Ir J Med Sci; 2022 Jun; 191(3):1385-1397. PubMed ID: 34131812
[TBL] [Abstract][Full Text] [Related]
3. Psychologists' and psychotherapists' knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics.
Kucsera A; Suppes T; Haug NA
Clin Psychol Psychother; 2023; 30(6):1369-1379. PubMed ID: 37394242
[TBL] [Abstract][Full Text] [Related]
4. [Psychedelics and treatment of mental disorders: A survey of attitudes and knowledge among psychiatrists, general practitioners and psychologists in Iceland].
Olafsson RP; Kvaran K; Ketilsdottir K; Hallgrimsdottir K; Sigurdsson EL; Sigurdsson E
Laeknabladid; 2023 Nov; 109(11):495-503. PubMed ID: 37909445
[TBL] [Abstract][Full Text] [Related]
5. United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.
Barnett BS; Parker SE; Weleff J
Int J Drug Policy; 2022 Jan; 99():103473. PubMed ID: 34624734
[TBL] [Abstract][Full Text] [Related]
6. Psychotherapists' openness to engage their patients in Psilocybin-Assisted Therapy for mental health treatment.
Meir P; Taylor L; Soares JC; Meyer TD
J Affect Disord; 2023 Feb; 323():748-754. PubMed ID: 36535547
[TBL] [Abstract][Full Text] [Related]
7. Medical student attitudes and perceptions of psychedelic-assisted therapies.
Li I; Fong R; Hagen M; Tabaac B
Front Psychiatry; 2023; 14():1190507. PubMed ID: 37441143
[TBL] [Abstract][Full Text] [Related]
8. Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia.
Glynos NG; Pierce J; Davis AK; McAfee J; Boehnke KF
J Psychoactive Drugs; 2023; 55(1):73-84. PubMed ID: 35001856
[TBL] [Abstract][Full Text] [Related]
9. UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study.
Song-Smith C; Jacobs E; Rucker J; Saint M; Cooke J; Schlosser M
BMJ Open; 2024 Mar; 14(3):e083595. PubMed ID: 38485474
[TBL] [Abstract][Full Text] [Related]
10. Psychedelic-Assisted Group Therapy: A Systematic Review.
Trope A; Anderson BT; Hooker AR; Glick G; Stauffer C; Woolley JD
J Psychoactive Drugs; 2019; 51(2):174-188. PubMed ID: 30950777
[TBL] [Abstract][Full Text] [Related]
11. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.
Barnett BS; Greer GR
J Acad Consult Liaison Psychiatry; 2021; 62(4):460-471. PubMed ID: 34210406
[TBL] [Abstract][Full Text] [Related]
12. Predictors of Medical Students' Perceptions of Psilocybin-Assisted Therapy for Use in Medical Practice.
Wang K; Sun Y; Nava B; Sampiere L; Jacobs RJ
Cureus; 2023 Apr; 15(4):e37450. PubMed ID: 37181969
[TBL] [Abstract][Full Text] [Related]
13. Compassionate use of psychedelics.
Greif A; Šurkala M
Med Health Care Philos; 2020 Sep; 23(3):485-496. PubMed ID: 32468195
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal associations between psychedelic use and unusual visual experiences in the United States and the United Kingdom.
Simonsson O; Hendricks PS; Stenfors CU; Goldberg SB; Honk L; Osika W
J Psychopharmacol; 2024 Jan; 38(1):110-115. PubMed ID: 38140891
[TBL] [Abstract][Full Text] [Related]
15. Psychedelics and Psychedelic-Assisted Psychotherapy.
Reiff CM; Richman EE; Nemeroff CB; Carpenter LL; Widge AS; Rodriguez CI; Kalin NH; McDonald WM;
Am J Psychiatry; 2020 May; 177(5):391-410. PubMed ID: 32098487
[TBL] [Abstract][Full Text] [Related]
16. Cessation and reduction in alcohol consumption and misuse after psychedelic use.
Garcia-Romeu A; Davis AK; Erowid F; Erowid E; Griffiths RR; Johnson MW
J Psychopharmacol; 2019 Sep; 33(9):1088-1101. PubMed ID: 31084460
[TBL] [Abstract][Full Text] [Related]
17. Animal Behavior in Psychedelic Research.
Odland AU; Kristensen JL; Andreasen JT
Pharmacol Rev; 2022 Oct; 74(4):1176-1205. PubMed ID: 36180111
[TBL] [Abstract][Full Text] [Related]
18. Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.
Bender D; Hellerstein DJ
Psychopharmacology (Berl); 2022 Jun; 239(6):1907-1932. PubMed ID: 35022823
[TBL] [Abstract][Full Text] [Related]
19. Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness.
Holoyda B
Psychiatr Serv; 2020 Dec; 71(12):1297-1299. PubMed ID: 33050796
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
